Cable Viewer

Currently released so far... 14569 / 251,287

### Articles

Brazil Sri Lanka United Kingdom Sweden 00. Editorial United States Latin America Egypt Jordan Yemen

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05 2011/06
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23 2011/05/24 2011/05/25 2011/05/26 2011/05/27 2011/05/28 2011/05/29 2011/05/30 2011/05/31
2011/06/01 2011/06/02 2011/06/03 2011/06/04 2011/06/05 2011/06/06 2011/06/07 2011/06/08 2011/06/09

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 95 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05 1986/08
1987/06
1988/01 1988/03 1988/07 1988/08
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/03 1992/06 1992/09 1992/12
1993/01 1993/10
1994/12
1995/01 1995/04
1996/07 1996/11
1997/02 1997/05 1997/06 1997/10 1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/05 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Belfast Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Mission Geneva Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana Consulate Thessaloniki
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ASEC AEMR AMGT AR APECO AU AORC AJ AF AFIN AS AM ABLD AFFAIRS APER AA AG AE ADM ALOW ACOA ATRN AID AND ADANA APEC ARABL ADPM ADCO AADP AL AMED AY AORG ASEAN ABUD AO ARF AGRICULTURE AGAO AROC AINF APCS AODE ACABQ AX AMEX AZ ASUP ARM AQ ATFN AMBASSADOR ACBAQ AFSI AFSN AC ASIG ASEX AER AVERY ASCH AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL AN AIT ANET AGMT ACS AGR AMCHAMS AECL AUC AFGHANISTAN ACAO
BR BB BG BEXP BY BA BRUSSELS BU BD BK BL BH BM BO BTIO BE BIDEN BX BILAT BP BC BF BBSR BT BMGT BWC BN BTIU
CPAS CA CASC CS CBW CIDA CO CODEL CI CROS CU CH CWC CMGT CVIS CDG CD CV CG CF CHIEF CJAN CBSA CE CY CT CM CR CONS CW CDC CN CONDOLEEZZA CICTE CYPRUS COUNTRY CARICOM CBE COE COM CIVS CACS COPUOS CFED CARSON CAPC COUNTER CTR CKGR CHR CVR CLINTON COUNTERTERRORISM CITEL CLEARANCE CB CSW CIC CITT CARIB CAFTA CZ CACM CDB CJUS CTM CAN CONSULAR CLMT CBC CIA CNARC CIS CEUDA CHINA CAC CL
DR DJ DHS DAO DCM DO DEFENSE DOMESTIC DK DOD DA DE DPRK DEPT DEA DISENGAGEMENT DOE DTRA DS DEAX
ECON ETTC EFIS ETRD EC EMIN EAGR EAID EU EFIN EUN ECIN EG EWWT EINV ENRG ELAB EPET EN EAIR EUMEM ECPS ELTN EIND EZ EI ER ET EINT ECONOMIC ENIV EFTA ES ECONOMY ELECTIONS EXIM ENERG EK EDEV ERNG EPA ENGR ETRC ENVI EXTERNAL ELN EAIDS ECA EFINECONCS EINVEFIN EUREM ECOSOC EDU ETRDEINVECINPGOVCS ETC ENVR EAP EINN EXBS ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN ETRDEINVTINTCS ECIP EFIM EREL EINVETC ECONCS ETRA ESA EAIG EUR EUC ERD ETRN EINVECONSENVCSJA EEPET EUNCH ESENV ENNP ECINECONCS ETRO ETRDECONWTOCS ECUN
FR FI FAS FOREIGN FTAA FREEDOM FBI FINANCE FAA FJ FTA FARC FAC FAO FINR FM FDA FOR FOI FO FMLN FISO
GM GG GERARD GT GA GR GTIP GLOBAL GV GL GOV GOI GF GH GANGS GE GTMO GCC GAERC GZ GAZA GY GUILLERMO GASPAR
HR HO HA HYMPSK HK HUMAN HU HILLARY HI HUM HURI HSTC HEBRON HUMOR
IZ IN IAEA IS IMO ILO IR IC IT ITU IV IMF IBRD IWC ITRA IRAQI IDB ISRAELI ITALY ITPGOV ITALIAN INDO ICAO ID IPR INMARSAT ICRC INTERNAL IIP ILC IRS ICJ IO IQ ICTY IEFIN IA INTERPOL IEA INR INRB IAHRC ISRAEL IZPREL IRAJ IF ITPHUM IL IACI IDA ISLAMISTS IGAD ITF INRA INRO IBET INTELSAT IDP ICTR IRC
JA JO JM JP JUS JOHN JOSEPH JOHNNIE JAMES JIMENEZ
KOMC KNNP KFLO KDEM KSUM KIPR KFLU KPAO KE KCRM KJUS KAWC KZ KSCA KDRG KCOR KGHG KPAL KTIP KMCA KCRS KPKO KOLY KRVC KVPR KG KWBG KMDR KTER KSPR KV KTFN KWMN KFRD KSTH KS KN KISL KGIC KSEP KFIN KTEX KTIA KUNR KCMR KMOC KCIP KTDB KBIO KU KSTC KIRC KICC KSEO KSAF KPWR KIDE KIRF KR KNUP KCSY KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KOCI KMPI KNUC KPAONZ KHLS KPRP KHDP KHIV KTRD KWAC KTAO KJUST KTBT KACT KCRCM KNPP KPRV KNAR KAWK KBCT KMFO KCFE KVIR KX KENV KNDP KMRS KBTS KHSA KSCI KVRP KFSC KPOA KNNPMNUC KO KERG KPIR KCOM KAID KTLA KRCM KCFC KNEI KCHG KPLS KREL KFTFN KTFM KLIG KDEMAF KRAD KBTR KGIT KGCC KICA KHUM KSEC KPIN KESS KDEV KWWMN KOM KWNM KRFD KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KRGY KREC KIFR KSAC KWMNCS KPAK KOMS KFPC KRIM KDDG KCGC KPAI KID KMIG KNSD KWMM
LY LE LABOR LU LTTE LA LI LG LO LH LAB LT LOG
MARR MX MASS MOPS MNUC MCAP MTCRE ML MR MRCRE MTRE MASC MY MK MAS MO MIL MTCR MG MAPP MAR MU MZ MD MP MA MOPPS MTS MLS MILI MEPN MEPI MEETINGS MERCOSUR MW MT MCC MIK MAPS MV MILITARY MARAD MDC MEPP MASSMNUC MUCN MEDIA MI MQADHAFI MPOS MPS MC
NZ NATO NI NO NG NL NU NPT NS NC NA NATIONAL NSF NDP NIPP NSSP NP NE NR NGO NAS NZUS NH NSG NAFTA NEW NRR NT NASA NAR NK NOVO NATOPREL NEA NSC NV NPA NSFO NW NORAD NPG
OTRA OECD OVIP OREP OPRC ODC OIIP OPDC OAS OSCE OPIC OMS OEXC OPCW OPAD ODIP OVIPPRELUNGANU OIE OFDP OHUM OFFICIALS OSCI OTR OMIG OSAC OBSP OFDA OVP ON OCII OES OCS OIC
PGOV PREL PARM PINR PHUM PM PREF PTER PK PINS PBIO PHSA PE PBTS PL POL PAK POV POLITICS POLICY PERL PA PCI PAS PALESTINIAN PNAT PPA PROP PREZ PRELPK PAIGH PO PROG POLITICAL PJUS PMIL PRAM PGOF PAO PARMS PG PREO PINO PDOV PSI PTERE PTE PRGOV PORG PP PS PKFK PSOE PEPR PDEM PINT PMAR PRELP PREFA PNG PTBS PFOR PUNE PGOVLO PHUMBA POLINT PGOVE PHALANAGE PARTY PECON PY PLN PHUH PEDRO PF PHUS PU PARTIES PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PHUMPREL POGOV PEL PINL PBT PINF PRL PSEPC POSTS PAHO PHUMPGOV PGOC PNR PROV
QA
RS RP RU RW RFE RCMP RIGHTSPOLMIL ROBERT RM RICE ROOD RELAM RO REGION RSP RF RELATIONS RIGHTS RUPREL REMON REACTION REPORT RSO
SZ SENV SOCI SNAR SY SO SP SU SI SMIG SYR SA SCUL SG SW SR SYRIA SNARM SPECIALIST SEN SC SF SENVSXE SARS SL SAARC SNARIZ SCRS SWE STEINBERG SN SAN ST SIPDIS SSA SPCVIS SOFA SENVKGHG SANC SHI SEVN SHUM SK SH SNARCS SPCE SNARN SIPRS
TRGY TBIO TSPA TU TPHY TI TX TH TIP TSPL TNGD TP TW TZ TN TC TS TF TT TK TD TWI TERRORISM TL TV TO TRSY TURKEY TSPAM TINT TFIN TAGS TR TBID THPY
UK UNSC UNGA UN US UZ USEU UV UG UP UNAUS UNMIK USTR UR UY USPS UNSCR UNHRC UNMIC UNESCO UNCHR USUN UNHCR USGS UNEP USNC USOAS USAID UE UNVIE UAE UNO UNDP UNODC UNCHS UNFICYP UNDESCO UNC UNPUOS UNDC UNICEF UNCHC UNCSD UNFCYP UNIDROIT UNCND
VE VM VT VZ VTEG VTIZ VTPREL VENZ VAT VC VI VN
WHTI WIPO WTRO WS WHO WTO WA WZ WI WBG WMD WWARD WHA WITH WTRQ WEU WMO WFP WB
XA XR XW XX XK XL XM XS XF XG XT XH XB XU XE XV XD XC XY XZ XQ XI XTAG
YI YM YL YMCS YE
ZU ZI ZP ZR ZOELLICK ZF ZO ZL ZB ZH ZT ZJ ZEALAND ZN ZA ZK ZANU

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 04WELLINGTON596, NEW ZEALAND-AUSTRALIA REGULATORY AGENCY TO RAISE

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04WELLINGTON596.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
04WELLINGTON596 | 2004-07-13 04:34 | 2011-04-28 00:00 | CONFIDENTIAL | Embassy Wellington

`

    This record is a partial extract of the original cable. The full text of the original cable is not available.

` `

    C O N F I D E N T I A L SECTION 01 OF 02 WELLINGTON 000596

    SIPDIS

    STATE PASS USTR FOR BWEISEL
    STATE PASS FDA FOR OFFICE OF INTERNATIONAL PROGRAMS/WALTER
    BATTS AND JULIA HO
    STATE FOR EAP/ANP AND EB/TPP/BTA/ANA
    COMMERCE FOR 4530/ITA/MAC/AP/OSAO/GPAINE

    E.O. 12958: DECL: 07/12/2014
    TAGS: ETRD NZ
    SUBJECT: NEW ZEALAND-AUSTRALIA REGULATORY AGENCY TO RAISE
    INDUSTRY'S COSTS

    REF: A. AUCKLAND 118
         ¶B. 03 WELLINGTON 1273
         ¶C. 03 WELLINGTON 1191
         ¶D. 01 WELLINGTON 798

    (U) Classified by DCM David R. Burnett.  Reasons: 1.5 (b) and
    (d).

    ¶1. (C) Summary:  U.S. makers of medical devices and dietary
    and nutritional supplements face the prospect of additional
    regulatory costs to enter the New Zealand market -- but
    perhaps not as high as the industry had feared.  An
    Australian-New Zealand authority to regulate therapeutic
    products in both countries probably will accept U.S.
    certification of products, and not just European
    certification, as the industry had expected.  On the other
    hand, the agency will aim to recover all regulatory costs
    from the industry.  Representatives of U.S. manufacturers
    fear such costs could drive many of their products out of the
    New Zealand market.

    ¶2. (U) Meanwhile, the pharmaceutical industry has endorsed
    the joint authority, while worrying that the agency will ban
    direct-to-consumer advertising.  Such advertising has helped
    a number of pharmaceutical companies to boost sales of
    unsubsidized medicines in New Zealand.  It has provided one
    of the few means available in a highly restricted market for
    pharmaceutical manufacturers to build sales for products that
    consumers pay for entirely out of pocket.  End summary.

    New regulation
    --------------
    ¶3. (U) The Australian and New Zealand health ministers signed
    a treaty December 10 to set up a trans-Tasman agency to
    regulate therapeutic products, including medical devices,
    prescription and over-the-counter medicines, dietary and
    nutritional supplements, and cosmetics and toiletries (ref
    B).  When the agency opens its doors in July 2005, it will
    replace the Australian Therapeutic Goods Administration (TGA)
    and the New Zealand Medicines and Medical Devices Safety
    Authority (Medsafe).  Both governments are jointly working to
    establish a framework for the agency and instructions for any
    necessary legislation.

    ¶4. (U) For New Zealand, the agency offered a solution to a
    long-acknowledged deficiency.  Medical devices and
    health-care products have been virtually unregulated in the
    country.  Medsafe does evaluate pharmaceuticals before
    allowing them on the market.  An adviser to the health
    ministers suggested the cost to New Zealand of participating
    in the joint agency would be less than if it had tried on its
    own to extend its regulatory authority to devices and other
    non-drug medical products.

    Higher costs
    ------------
    ¶5. (C) Nonetheless, the adviser, Selwyn Katene, acknowledged
    that New Zealand's regulatory costs would increase
    significantly under the joint agency.  For example, the
    number of New Zealand-based staff members needed by the new
    agency would be at least double the 35 people who now staff
    Medsafe.  Moreover, Katene noted that all the agency's costs
    would be passed on to the industry.  Fees for registering
    products would be set to recover the costs of regulation,
    although Katene said his government recognizes it may need to
    phase in such fees to alleviate the pain to industry.  But
    with regulation over non-drug products, Katene said, "the
    industry's halcyon days are over."  Many distributors of
    medical devices and complementary goods expect the higher
    fees to harm their sales in New Zealand (ref C).  They
    advocate setting fees according to the size of the product's
    market, with Australia's population being five times that of
    New Zealand.

    ¶6. (C) The joint authority initially had intended to require
    additional documentation and possibly a quality-control audit
    for products that do not have European certification yet have
    U.S. Food and Drug Administration (FDA) approval.  However,
    Katene -- who asked that his comments July 9 not be shared
    with industry -- said New Zealand Minister of Health King had
    decided that requiring two certification processes was
    unreasonable.

    ¶7. (C) That decision should greatly relieve representatives
    of U.S. medical-device manufacturers, who have argued that
    additional certification would increase the cost and time for
    marketing their products.  A number of representatives met
    with King on June 25 and -- according to Katene -- influenced
    her thinking on the issue.  Katene, a New Zealander, serves
    as secretary to the joint agency's ministerial council, which
    is composed of the two health ministers.  They will appoint
    the agency's five governing board members.

    Advertising's future
    --------------------
    ¶8. (C) On June 17, the Researched Medicines Industry
    Association of New Zealand (RMI) -- the pharmaceutical
    industry association -- announced in a news release its
    support of the joint agency.  Lesley Clarke, RMI's chief
    executive, said July 9 that the association had long backed
    the concept of a joint authority, since it would provide one
    point of entry for pharmaceutical companies to both Australia
    and New Zealand.  RMI issued the news release to bolster
    parliamentary support for the agency, after the media
    reported that the agency's compliance requirements could put
    medical-device and complementary-goods companies out of
    business.

    ¶9. (C) However, the pharmaceutical industry worries that the
    new agency could mean an end to its ability to advertise its
    unsubsidized prescription medicines directly to New Zealand
    consumers (ref A).  Australia allows only disease-based,
    awareness-building advertising, with no mention of product
    names.  Some pharmaceutical companies have built a
    significant private purchase market in New Zealand -- in one
    case, as much as one-third of its sales -- as a way to
    counter the limits of a system of government-subsidized sales.

    ¶10. (C) On that issue, Katene would say only that Minister
    King had been instructed by the cabinet to "harmonize" with
    Australia and that a decision for or against
    direct-to-consumer advertising had not been made.
    "Harmonization" generally has been thought to refer to New
    Zealand's adopting the Australian rules, with Australia
    seeing no need to change.

    ¶11. (C) Clarke said that, other than Minister King, members
    of Parliament are supportive of or ambivalent about
    direct-to-consumer advertising.  Only Minister King appears
    to be adamantly against it, joining a small doctors' group --
    and no consumer groups -- that advocates a ban.  Clarke
    predicted that such advertising would continue to be allowed,
    with a ban requiring the repeal of existing law and with
    Minister King lacking her colleagues' support.

    ¶12. (C) Comment: Allowing FDA certification would remove one
    potentially discriminatory barrier to U.S. products.  Post
    remains concerned, however, about the potential decline in
    sales of U.S. medical devices and other therapeutic products
    due to anticipated higher regulatory costs and about the
    possibility that pharmaceutical companies -- already
    constrained by New Zealand government policy -- would lose
    their ability to generate private sales through advertising.
    Post hopes these concerns could be conveyed in the Trade and
    Investment Framework Agreement talks with New Zealand
    scheduled for July 20.
    Swindells

`